In silico identification and validation of triarylchromones as potential inhibitor against main protease of severe acute respiratory syndrome coronavirus 2
- 3 May 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in Journal of Biomolecular Structure and Dynamics
- Vol. 40 (19), 8850-8865
- https://doi.org/10.1080/07391102.2021.1918255
Abstract
The ongoing pandemic due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused COVID-19 has emerged as a severe threat to the life of human kind. The identification and designing of appropriate and reliable drug molecule for the treatment of COVID-19 patients is the pressing need of the present time. Among different drug targets, the main protease of SARS-CoV-2 is being considered as most effective target. In addition to the drug repurposing, different compounds of natural as well as synthetic origins are being investigated for their efficacy against different drug targets of SARS-CoV-2 virus. In that context, the chromone based natural flavonols have also exhibited significant antiviral properties against different targets of SARS-CoV-2. The in silico studies presented here discloses the efficacy of triarylchromones (TAC) as potential inhibitor against main protease of SARS-CoV-2. The molecular docking and ADMET study performed using 14 arylchromones which could easily be accessed through simple synthetic protocols, revealed best binding affinities in case of TAC-3 (–11.2 kcal/mol), TAC-4 (–10.5 kcal/mol), TAC-6 (–11.2 kcal/mol), TAC-7 (–10.0 kcal/mol). Additional validation studies including molecular dynamics simulation and binding energy calculation using MMGBSA for protein ligand complex for 100 ns revealed the best binding interaction of TAC-3, TAC-4, TAC-6, TAC-7 against main protease of SARS-CoV-2. Moreover, the in vitro and preclinical validation of identified compounds will help us to understand the molecular mechanisms of regulation of TACs against SARS-CoV-2. Communicated by Ramaswamy H. SarmaKeywords
This publication has 52 references indexed in Scilit:
- A Novel Coronavirus from Patients with Pneumonia in China, 2019The New England Journal of Medicine, 2020
- Chromone as a Privileged Scaffold in Drug Discovery: Recent AdvancesJournal of Medicinal Chemistry, 2017
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesScientific Reports, 2017
- Unraveling innate substrate control in site-selective palladium-catalyzed C–H heterocycle functionalizationChemical Science, 2016
- Ligand docking and binding site analysis with pymol and autodock/vinaInternational Journal of Basic and Applied Sciences, 2015
- Pd-catalyzed atom-economic couplings of triarylbismuth reagents with 2-bromo- and 2,6-dibromochromones and synthesis of medicinally important fisetinTetrahedron Letters, 2014
- Chromones as a privileged scaffold in drug discovery: A reviewEuropean Journal of Medicinal Chemistry, 2014
- Chromone: A Valid Scaffold in Medicinal ChemistryChemical Reviews, 2014
- Palladium-catalyzed oxidative arylation of chromones via a double C–H activation: an expedient approach to flavonesTetrahedron Letters, 2012
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009